Increased CYP2E1 activity correlates with the degree of steatosis and level of the inflammatory cytokines (e.g., TNF-α) involved in the pathology of NASH [6]. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatohepatitis.